Preferred Stock Channel
Market News Video Self Directed Investor The Warren Buffetts Next Door Stock message boards
Quotes delayed 20 minutes


Strong Buy (4.00 out of 4)
83rd percentile
(ranked higher than approx. 83% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com
www.valueforum.com/7/
Free Preferred Stock Newsletter
Gain access to weekly reports with featured preferred stock screens, new preferred stock offerings, and more.

Slideshow Preferred Stock Offerings

By Preferred Stock Channel Staff, updated Monday, April 23, 1:16 AM

Slide #3. Vermillion, Inc. Preferred Stock Offering

Company: Vermillion, Inc. (NASDAQ:VRML)
Date announced: 4/12/2018
Shares Offered: 50,000
Date of Pricing: 4/13/2018
Price Per Share: $100.00
Preferred Stock Offering Details: Vermillion, Inc. (Nasdaq:VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that it intends to offer shares of its common stock and convertible preferred stock in concurrent but separate underwritten public offerings. The convertible preferred stock is non-voting and convertible into shares of Vermillion, Inc. common stock automatically upon receipt of stockholder approval of the conversion. The offerings are subject to market and other conditions, and there can be no assurance as to whether or when the offerings may be completed, or as to the actual size or terms of the offerings. As part of the common stock offering, Vermillion, Inc. is expected to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock being offered at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any. The offerings are being conducted as separate public offerings by means of separate prospectus supplements, and neither offering is contingent upon the consummation of the other. All of the shares will be offered by Vermillion, Inc. -updated 4/13- Vermillion, Inc. (Nasdaq:VRML), a bio-analytical solutions company focused on gynecologic disease, today announced the pricing of the previously announced concurrent but separate underwritten public offerings of 10,000,000 shares of its common stock at a price to the public of $1.00 per share and 50,000 shares of its Series B Convertible Preferred Stock at a price to the public of $100.00 per share. Each share of Series B Convertible Preferred Stock is non-voting and convertible into 100 shares of Vermillion, Inc. common stock, based on an initial conversion price of $1.00 per share, automatically upon receipt of stockholder approval of the conversion. As part of the common stock offering, Vermillion, Inc. has granted the underwriter a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any. The offerings are being conducted as separate public offerings by means of separate prospectus supplements, and neither offering is contingent upon the consummation of the other. All of the shares are being offered by Vermillion, Inc. The offering is expected to close on April 17, 2018, subject to customary closing conditions.

Vermillion is engaged in discovering, developing and commercializing diagnostic and bio-analytical solutions that assist physicians diagnose, treat and improve outcomes for women. Co.'s tests are to detect, characterize and stage disease, and to assist guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in monitoring response to therapy. Co. focuses its development of diagnostic tests for gynecologic disease, with an initial focus on ovarian cancer. Co.'s main product, OVA1, is a blood test designed to identify women who are at high risk of having a malignant ovarian tumor prior to surgery.
Open the VRML Page at Preferred Stock Channel »

Name:  Vermillion Inc
Website:  www.vermillion.com
Sector:  Medical Instruments & Supplies
Number of ETFs Holding VRML:  5 (see which ones)
Total Market Value Held by ETFs:  $114,335
Total Market Capitalization:  $71,000,000
% of Market Cap. Held by ETFs:  0.16%
 

Open the VRML Page at Preferred Stock Channel (in a new window) »

Top Ten Highest Yielding Preferred Stocks
Feel-Good Income: Socially Responsible Preferreds
Dividend Channel's 25 S.A.F.E. Dividend Stocks
Increasing Payments For Decades

Safer than S.A.F.E: Preferreds of Dividend Channel's
S.A.F.E. Dividend Stocks

Recent Preferred Stock Offerings
Preferred Stocks of Dow Components
Preferred Stocks of S&P 500 Components
Preferred Stocks By Industry
Preferred Stocks Where Insiders Are Buying The Common
High Yield Preferred Stocks
Preferreds Trading At Premiums To Liquidation Preference
Preferreds Trading At Discounts To Liquidation Preference
The Top 10 DividendRank'ed U.S. Stocks
The Top 10 DividendRank'ed Canadian Stocks
Top 25 Broker Analyst Picks of the S&P 500
Stock market game

Preferred Stock Offerings - Slide 3 of 422 | www.PreferredStockChannel.com | Copyright © 2011 - 2018, All Rights Reserved

Nothing in Preferred Stock Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Preferred Stock Channel; Meet Our Editorial Staff.